Paliperidone and Clindamycin Recalls
Two drugs, Paliperidone extended-release tablets 3 mg and Clindamycin injection USP ADD-Vantage Vials, have been voluntarily recalled by their respective makers. While these appear to be minor drug recalls, all drug recalls should be taken seriously.
Paliperidone, distributed under the Actavis Pharma Inc. label was recalled by Teva Pharmaceuticals USA, Inc.. The tablets did not pass a dissolution test. This may lead to less of the drug being absorbed, thus they recalled the drug. When two or more doses of an affected product are taken, it may diminish the effectiveness of the drug. The chances of taking two or more doses of the affected product consecutively are low according to Teva. The recall affects one lot. The FDA has more information here on the drug and Teva.
Alvogen manufactures Clindamycin by Hospira Inc., a Pfizer Company. They issued a recall for Clindamycin because of a microbial growth identified in a simulation of the manufacturing process. Alvogen states this could lead to microorganisms in the drug. They have not received any reports of adverse reaction due to the product. Seven lots have been recalled with distribution between May 2016 and June 2017.
If you or a loved one has been harmed due to medical negligence make sure you obtain experienced legal representation. Contact a personal injury lawyer who will help you every step of the way. The Columbia, South Carolina law firm of Leventis & Ransom will fight to obtain the compensation you deserve. We offer a free case review and you pay no fees until we win for you. Contact us today by calling 803-765-2382 or email us at email@example.com or fill out our confidential online form.